Who invested in Leap Therapeutics?
Leap Therapeutics's investors include Winklevoss Capital. Winklevoss Capital led its latest round.

United States · Funded startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Leap Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$59Mraised across 1 round since 2025, from 1 source
Leap Therapeutics filed 2 raises, $95M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 6 on the team.
On the board, as filediChristian K. RichardJames K. CavanaughJoseph K. LoscalzoNissim K. MashiachPatricia K. MartinRichard K. SchilskyThomas K. DietzWilliam K. Li
Leap Therapeutics's investors include Winklevoss Capital. Winklevoss Capital led its latest round.
Leap Therapeutics has raised $59M across 1 round since 2025.
Leap Therapeutics's most recent round was an Undisclosed round of $59M in Oct 2025, led by Winklevoss Capital.
Its most recent round, $59M in Oct 2025, is also its largest on record.
Leap Therapeutics's first round on record, in Oct 2025, was backed by Winklevoss Capital.
Leap Therapeutics's latest named round is an Undisclosed round, in Oct 2025.
Leap Therapeutics is based in the United States.
Winklevoss Capital led the Undisclosed round in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.